{"altmetric_id":918997,"counts":{"readers":{"mendeley":7,"citeulike":0,"connotea":0},"total":{"posts_count":6},"twitter":{"unique_users_count":4,"unique_users":["T_R_D_","clashmore1","philipcrobinson","NatRevRheumatol"],"posts_count":6}},"selected_quotes":["Highlight - #tofacitinib (FDA-approved in RA) phase III results; why new oral DMARD is welcome for patients with #RA","Research highlight article at no 4 in our download chart describes phase III results for #tofacitinib in #RA (\u00a3)","AOP highlight: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with #RA"],"citation":{"altmetric_jid":"4f6fa52f3cf058f610004274","authors":["Emma Leah"],"doi":"10.1038\/nrrheum.2012.145","endpage":"","first_seen_on":"2012-08-29T12:30:59+00:00","issns":["1759-4790","1759-4804"],"journal":"Nature Reviews Rheumatology","last_mentioned_on":1352369895,"links":["http:\/\/www.nature.com\/nrrheum\/journal\/vaop\/ncurrent\/full\/nrrheum.2012.145.html?WT.mc_id=TWT_NatRevRheumatol"],"pmid":"22926344","pubdate":"2012-08-28T00:00:00+00:00","publisher":"Nature Publishing Group","scopus_subjects":["Medicine","Health Sciences"],"startpage":"","subjects":["rheumatology"],"title":"Clinical trials: Phase III trial results for tofacitinib bring new oral DMARD therapy a step closer for patients with rheumatoid arthritis","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/clinical-trials-phase-iii-trial-results-tofacitinib-bring-new-oral-dmard-therapy-step-closer-patient-3"},"altmetric_score":{"score":2.7,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.7},"context_for_score":{"all":{"total_number_of_other_articles":4505285,"mean":5.0995569853359,"rank":1621030,"this_scored_higher_than_pct":63,"this_scored_higher_than":2870306,"rank_type":"exact","sample_size":4505285,"percentile":63},"similar_age_3m":{"total_number_of_other_articles":78496,"mean":5.3323142365756,"rank":22183,"this_scored_higher_than_pct":71,"this_scored_higher_than":56022,"rank_type":"exact","sample_size":78496,"percentile":71},"this_journal":{"total_number_of_other_articles":770,"mean":5.5689622886866,"rank":364,"this_scored_higher_than_pct":52,"this_scored_higher_than":406,"rank_type":"exact","sample_size":770,"percentile":52},"similar_age_this_journal_3m":{"total_number_of_other_articles":50,"mean":1.7714285714286,"rank":11,"this_scored_higher_than_pct":78,"this_scored_higher_than":39,"rank_type":"exact","sample_size":50,"percentile":78}}},"demographics":{"poster_types":{"member_of_the_public":3,"science_communicator":1},"users":{"twitter":{"cohorts":{"Members of the public":3,"Science communicators (journalists, bloggers, editors)":1}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":1,"Other":2,"Student  > Bachelor":1,"Lecturer":1,"Lecturer > Senior Lecturer":1},"by_discipline":{"Medicine and Dentistry":6,"Chemistry":1}}},"geo":{"twitter":{"TR":1,"AU":1,"GB":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/T_R_D_\/status\/259716588389941250","rt":["NatRevRheumatol"],"citation_ids":[918997],"posted_on":"2012-10-20T18:03:54+00:00","author":{"name":"Romatolog","url":"http:\/\/www.nurullahakkoc.com","image":"https:\/\/pbs.twimg.com\/profile_images\/833982570593386496\/MwTpaKRo_normal.jpg","description":"Romatoloji Uzman\u0131, \u0130zmir","id_on_source":"T_R_D_","tweeter_id":"351696498","geo":{"lt":39.05901,"ln":34.91155,"country":"TR"},"followers":486},"tweet_id":"259716588389941250"},{"url":"http:\/\/twitter.com\/#!\/clashmore1\/status\/266471042627825665","rt":["NatRevRheumatol"],"citation_ids":[918997],"posted_on":"2012-11-08T09:23:42+00:00","author":{"name":"Twisha ","image":"http:\/\/a0.twimg.com\/profile_images\/3053224180\/1d8e480aa4cd749a5411c7b73c2c14b6_normal.jpeg","description":"Married to Paul. Three teenagers. H.R. Professional. Proud of my faith!","id_on_source":"clashmore1","tweeter_id":"186099819","followers":888},"tweet_id":"266471042627825665"},{"url":"http:\/\/twitter.com\/#!\/philipcrobinson\/status\/266484774305165312","rt":["NatRevRheumatol"],"citation_ids":[918997],"posted_on":"2012-11-08T10:18:15+00:00","author":{"name":"Philip Robinson","url":"http:\/\/brisbanerheumatology.com.au","image":"https:\/\/pbs.twimg.com\/profile_images\/741158167237775360\/Umv4cQ26_normal.jpg","description":"Rheumatologist; tweet health, healthcare, medicine, science & rheumatology mostly.","id_on_source":"philipcrobinson","tweeter_id":"246959615","geo":{"lt":-27.46794,"ln":153.02809,"country":"AU"},"followers":2213},"tweet_id":"266484774305165312"},{"url":"http:\/\/twitter.com\/#!\/NatRevRheumatol\/status\/240786381838880768","citation_ids":[918997],"posted_on":"2012-08-29T12:22:01+00:00","author":{"name":"NatRevRheumatol","url":"http:\/\/www.nature.com\/nrrheum\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1619045679\/nrrheum_Twitter_logo_normal.jpg","description":"Tweets from the editors of Nature Reviews Rheumatology, the top review journal in the field, covering the latest advances.","id_on_source":"NatRevRheumatol","tweeter_id":"403530978","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":5159},"tweet_id":"240786381838880768"},{"url":"http:\/\/twitter.com\/#!\/NatRevRheumatol\/status\/259210193710243840","citation_ids":[918997],"posted_on":"2012-10-19T08:31:40+00:00","author":{"name":"NatRevRheumatol","url":"http:\/\/www.nature.com\/nrrheum\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1619045679\/nrrheum_Twitter_logo_normal.jpg","description":"Tweets from the editors of Nature Reviews Rheumatology, the top review journal in the field, covering the latest advances.","id_on_source":"NatRevRheumatol","tweeter_id":"403530978","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":5159},"tweet_id":"259210193710243840"},{"url":"http:\/\/twitter.com\/#!\/NatRevRheumatol\/status\/266459079801712640","citation_ids":[918997],"posted_on":"2012-11-08T08:36:09+00:00","author":{"name":"NatRevRheumatol","url":"http:\/\/www.nature.com\/nrrheum\/index.html","image":"https:\/\/pbs.twimg.com\/profile_images\/1619045679\/nrrheum_Twitter_logo_normal.jpg","description":"Tweets from the editors of Nature Reviews Rheumatology, the top review journal in the field, covering the latest advances.","id_on_source":"NatRevRheumatol","tweeter_id":"403530978","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":5159},"tweet_id":"266459079801712640"}]}}